Accutane and Lo/ovral drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accutane and Lo/ovral. Common interactions include inflammatory bowel disease among females.

The phase IV clinical study analyzes what interactions people who take Accutane and Lo/ovral have. It is created by eHealthMe based on reports of 41 people who take Accutane and Lo/ovral from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 06, 2022

41 people who take Accutane and Lo/ovral together, and have interactions are studied.


What is Accutane?

Accutane has active ingredients of isotretinoin. It is often used in acne. eHealthMe is studying from 33,664 Accutane users for its effectiveness, alternative drugs and more.

What is Lo/ovral?

Lo/ovral has active ingredients of ethinyl estradiol; norgestrel. It is often used in birth control. eHealthMe is studying from 1,297 Lo/ovral users for its effectiveness, alternative drugs and more.

Number of Accutane and Lo/ovral reports submitted per year:

Accutane and Lo/ovral drug interactions.

Common Accutane and Lo/Ovral drug interactions by gender *:

female:

  1. Inflammatory bowel disease
  2. Colitis
  3. Pancreatitis
  4. Psychotic disorder
  5. Agoraphobia
  6. Intestinal haemorrhage
  7. Lip dry
  8. Tenosynovitis stenosans
  9. Nasal dryness
  10. Asthma

male:

n/a

Common Accutane and Lo/Ovral drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Vomiting
  2. Anion gap increased
  3. Arthropathy
  4. Blood urea decreased
  5. Chondromalacia
  6. Dermal cyst
  7. Skin depigmentation
  8. Stress at work
  9. Tinnitus
  10. Vaginal haemorrhage

20-29:

  1. Aggression
  2. Anxiety
  3. Colitis
  4. Depression
  5. Epstein-barr virus infection
  6. Inflammatory bowel disease
  7. Mood altered
  8. Night blindness
  9. Pancreatitis
  10. Panic attack

30-39:

  1. Depression
  2. Lip dry
  3. Panic attack
  4. Suicidal ideation
  5. Suicide attempt
  6. Abdominal abscess
  7. Abdominal adhesions
  8. Abdominal hernia
  9. Colitis
  10. Nasal dryness

40-49:

  1. Neurodermatitis

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Asthma: 9 people, 21.95%

* Approximation only. Some reports may have incomplete information.

Do you take Accutane and Lo/ovral?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Accutane and Lo/ovral interactions:

Browse all drug interactions of Accutane and Lo/ovral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accutane side effects:

Browse all side effects of Accutane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lo/ovral side effects:

Browse all side effects of Lo/ovral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accutane interactions:

Browse all interactions between Accutane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isotretinoin and ethinyl estradiol; norgestrel (the active ingredients of Accutane and Lo/ovral, respectively), and Accutane and Lo/ovral (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Accutane and Lo/ovral.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: